Man Group PLC Ironwood Pharmaceuticals Inc Transaction History

Man Group PLC

$37.6 Billion
Q2 2024

A detailed history of Man Group PLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Man Group PLC holds 2,984,451 shares of IRWD stock, worth $12.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,984,451

Previous 2,985,313 0.03%

Holding current value

$12.9 Million

Previous $26 Million 25.17%

% of portfolio

0.05%

Previous 0.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$5.58 - $8.61 $4,809 - $7,421	-862 Reduced 0.03%	2,984,451 $19.5 Million
Q1 2024 May 15, 2024	BUY	$8.32 - $15.45 $13 Million - $24.1 Million	1,559,924 Added 109.44%	2,985,313 $26 Million
Q4 2023 Feb 14, 2024	SELL	$8.79 - $11.51 $11.1 Million - $14.6 Million	-1,268,143 Reduced 47.08%	1,425,389 $16.3 Million
Q3 2023 Nov 14, 2023	SELL	$8.25 - $11.35 $2.33 Million - $3.21 Million	-282,518 Reduced 9.49%	2,693,532 $25.9 Million
Q2 2023 Aug 14, 2023	BUY	$10.1 - $11.6 $16 Million - $18.4 Million	1,587,429 Added 114.32%	2,976,050 $31.7 Million
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $43,045 - $52,136	4,151 Added 0.3%	1,388,621 $14.6 Million
Q4 2022 Feb 14, 2023	BUY	$9.9 - $12.43 $5.41 Million - $6.79 Million	546,193 Added 65.16%	1,384,470 $17.2 Million
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $6.41 Million - $7.83 Million	632,397 Added 307.17%	838,277 $8.68 Million
Q2 2022 Aug 15, 2022	SELL	$11.05 - $12.72 $115,240 - $132,656	-10,429 Reduced 4.82%	205,880 $2.37 Million
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $707,527 - $858,902	-66,685 Reduced 23.56%	216,309 $2.72 Million
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $179,070 - $230,021	-16,489 Reduced 5.51%	282,994 $3.3 Million
Q3 2021 Nov 15, 2021	SELL	$11.92 - $13.92 $1.14 Million - $1.33 Million	-95,551 Reduced 24.19%	299,483 $3.91 Million
Q2 2021 Aug 16, 2021	BUY	$10.16 - $13.11 $2.12 Million - $2.74 Million	208,808 Added 112.13%	395,034 $5.08 Million
Q1 2021 May 17, 2021	SELL	$9.04 - $11.86 $13.8 Million - $18.2 Million	-1,531,745 Reduced 89.16%	186,226 $2.08 Million
Q4 2020 Feb 16, 2021	SELL	$9.05 - $12.2 $2.78 Million - $3.75 Million	-307,697 Reduced 15.19%	1,717,971 $19.6 Million
Q3 2020 Nov 16, 2020	BUY	$8.99 - $10.74 $10.4 Million - $12.4 Million	1,154,168 Added 132.43%	2,025,668 $18.2 Million
Q2 2020 Aug 14, 2020	BUY	$9.14 - $11.97 $727,882 - $953,254	79,637 Added 10.06%	871,500 $8.99 Million
Q1 2020 May 15, 2020	BUY	$8.58 - $14.01 $5.33 Million - $8.71 Million	621,395 Added 364.52%	791,863 $7.99 Million
Q4 2019 Feb 18, 2020	BUY	$8.22 - $14.0 $1.4 Million - $2.39 Million	170,468 New	170,468 $2.27 Million
Q2 2019 Aug 14, 2019	SELL	$9.8 - $12.89 $878,344 - $1.16 Million	-89,627 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$8.27 - $12.73 $443,718 - $683,015	53,654 Added 149.15%	89,627 $1.21 Million
Q4 2018 Feb 14, 2019	SELL	$7.8 - $16.13 $713,926 - $1.48 Million	-91,529 Reduced 71.79%	35,973 $373,000
Q3 2018 Nov 14, 2018	BUY	$14.31 - $17.65 $1.82 Million - $2.25 Million	127,502 New	127,502 $2.35 Million

Others Institutions Holding IRWD

# of Institutions

239

Shares Held

164M

Call Options Held

11.2M

Put Options Held

28.5K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $660M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account